Literature DB >> 16405519

Variable therapeutic effectiveness of clopidogrel in acute coronary syndromes.

S Heptinstall1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16405519     DOI： 10.1111/j.1538-7836.2005.01777.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  4 in total

1.  Pharmacokinetics, pharmacodynamics, safety and tolerability of multiple ascending doses of ticagrelor in healthy volunteers.

Authors:  Kathleen Butler; Renli Teng
Journal:  Br J Clin Pharmacol       Date:  2010-07       Impact factor: 4.335

Review 2.  Comparing newer oral anti-platelets prasugrel and ticagrelor in reduction of ischemic events-evidence from a network meta-analysis.

Authors:  Saurav Chatterjee; Abhimanyu Ghose; Abhishek Sharma; Gunjan Guha; Debabrata Mukherjee; Robert Frankel
Journal:  J Thromb Thrombolysis       Date:  2013-10       Impact factor: 2.300

3.  Pharmacokinetics, pharmacodynamics, tolerability and safety of single ascending doses of ticagrelor, a reversibly binding oral P2Y(12) receptor antagonist, in healthy subjects.

Authors:  Renli Teng; Kathleen Butler
Journal:  Eur J Clin Pharmacol       Date:  2010-01-21       Impact factor: 2.953

Review 4.  Ticagrelor: the first reversibly binding oral P2Y12 receptor antagonist.

Authors:  Steen Husted; J J J van Giezen
Journal:  Cardiovasc Ther       Date:  2009       Impact factor: 3.023
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.